BA
The Boeing Company
BA's fundamentals are strong: its operating margin went from −10% to 10% and revenue grew 18%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
EVEX
Eve Holding, Inc.
There isn't enough reported data to score EVEX yet.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
EVEX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
EVEX's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
EVEX PE Valuation
EVEX has no meaningful PE right now: it lost money over the past year.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
EVEX Forward outlook
There aren't enough analyst estimates for EVEX to show an outlook.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over EVEX on earnings quality, reporting a profit while its opponent remains loss making.
EVEX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.65 | $0.00 |
| Q2 2026 | -$0.63 | $0.00 |
| Q1 2026 | -$0.74 | -$0.19 |
| Q4 2025 | -$0.70 | -$0.22 |
| Q3 2025 | -$0.65 | -$0.16 |
| Q2 2025 | -$0.63 | -$0.15 |
| Q1 2025 | -$0.55 | -$0.09 |
| Q4 2024 | -$0.48 | -$0.02 |
EVEX lost $0.65 per share over the past year, about the same as its loss the year before.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
EVEX Quarterly Revenue
EVEX and BA do not have enough comparable growth data to identify a winner.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over EVEX on cash generation, producing positive trailing cash flow while its opponent burns cash.
EVEX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$53M | +$7.7M |
| Q2 2026 | -$48.3M | +$8.6M |
| Q1 2026 | -$68.6M | -$43.3M |
| Q4 2025 | -$30M | +$9.9M |
| Q3 2025 | -$60.7M | -$26.7M |
| Q2 2025 | -$56.9M | -$25.5M |
| Q1 2025 | -$25.3M | +$10.6M |
| Q4 2024 | -$39.9M | -$15.4M |
EVEX has burned cash in almost every quarter: −$200M over the past year, against −$183M the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has the edge over EVEX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
EVEX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +123K shares |
| 1 year | +7.9% | +25.8M shares |
| 3 years | +28% | +76.1M shares |
EVEX has 352M diluted shares, up 7.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
EVEX Net Leverage
EVEX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
EVEX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.2 | Neutral |
| Stochastic | 19.1 | Oversold |
EVEX's weekly RSI is 39 (neutral) and its Stochastic is 19 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
EVEX PE vs Industrials Sector
EVEX has no meaningful PE right now: it lost money over the past year.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
EVEX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.74 | 1.7% above |
| 20 week MA | $2.13 | 17% below |
| 50 week MA | $2.86 | 38% below |
| 100 week MA | $3.76 | 53% below |
| 200 week MA | $4.94 | 64% below |
EVEX has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has the edge over EVEX on returns for 2026, with the stronger performance.
EVEX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $10.4 | $10.2 | -2.5% |
| 2022 | $10.2 | $7.49 | -26% |
| 2023 | $7.49 | $7.32 | -2.3% |
| 2024 | $7.32 | $5.41 | -26% |
| 2025 | $5.41 | $4.25 | -21% |
| 2026 YTD | $4.25 | $1.77 | -58% |
EVEX has finished every year since 2021 lower, and it's down 58% so far in 2026.